IQVIA Holdings
IQV
245.82
-4.73
-1.89%
IQVIA Holdings
US · IQV
#493 by market cap
Listed 1970
245.82
-4.73
-1.89%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 101.92% -0.04pp
- Institutions
- 1,469 -4
- As of
- 2026/Q4 vs. prior period
Holder types
Mutual Fund81.06%
Hedge Fund6.50%
Government4.10%
Public Company3.68%
Private Company1.93%
Government Pension Fund1.80%
Sovereign Wealth Fund1.46%
Individual/Insider0.97%
Family Office/Trust0.63%
Top holders as of 2026-09-30
BlackRock
8.76% · 14.43M sh
Vanguard Capital Management, LLC
7.10% · 11.71M sh
Harris Associates L.P.
6.34% · 10.45M sh
State Street Global Advisors
4.56% · 7.52M sh
Vanguard Portfolio Management, LLC
4.47% · 7.36M sh
Singapore
3.97% · 6.54M sh
Geode Capital Management, LLC
2.69% · 4.43M sh
Boston Partners Global Investors, Inc.
2.65% · 4.37M sh
Artisan Partners Limited Partnership
2.10% · 3.46M sh
J.P. Morgan Asset Management, Inc.
2.02% · 3.33M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 37 buys · 13 sells
| Name | Role | Stake |
|---|---|---|
| Ari Bousbib | Chairperson & CEO | 0.84% |
| Ronald Bruehlman | Former Chief Financial Officer | 0.03% |
| John Danhakl | Independent Director | 0.02% |
| Alistair Grenfell | President of Commercial Solutions | 0.01% |
| Eric Sherbet | General Counsel | 0.01% |
| Bernard Haas | Former Executive Vice President of AI & Technology Solutions | 0.01% |
| John Leonard | Lead Independent Director | 0.01% |
| Colleen Goggins | Independent Director | 0.01% |
| W. Staub | President of Research & Development Solutions | 0.01% |
| James Berkshire | Executive Vice President of Global Infrastructure & Operations | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-08 | Eric Sherbet | General Counsel | Derivative Exercise and Sale | -8,436 | $131.82–278.83 |
| 2026-11-04 | John Danhakl | Independent Director | Other Derivative Acquisition | +134 | -- |
| 2026-11-04 | Leslie Morris | Independent Director | Other Derivative Acquisition | +125 | -- |
| 2026-11-04 | Colleen Goggins | Independent Director | Other Derivative Acquisition | +144 | -- |
| 2026-11-04 | James Fasano | Independent Director | Other Derivative Acquisition | +154 | -- |
| 2026-09-01 | James Berkshire | Executive Vice President of Global Infrastructure & Operations | Derivative Exercise and Sale | -5,381 | $131.82–261.54 |
| 2026-08-02 | W. Staub | President of Research & Development Solutions | Open Market Disposition | -5,500 | $232.68 |
| 2026-07-30 | Bhavik Patel | President of MedTech & Consumer Health | Open Market Disposition | -1,855 | $235.27 |
| 2026-07-28 | Ari Bousbib | Chairperson & CEO | Derivative Exercise and Sale | -156,206 | $78.21–247.10 |
| 2026-07-28 | Eric Sherbet | General Counsel | Open Market Disposition | -5,000 | $249.16 |
| 2026-07-28 | Keriann Cherofsky | Senior VP, Corporate Controller & Chief Accounting Officer | Open Market Disposition | -558 | $245.21 |
| 2026-07-13 | John Danhakl | Independent Director | Other Derivative Acquisition | +160 | -- |
| 2026-07-13 | Leslie Morris | Independent Director | Other Derivative Acquisition | +148 | -- |
| 2026-07-13 | Colleen Goggins | Independent Director | Other Derivative Acquisition | +183 | -- |
| 2026-07-13 | James Fasano | Independent Director | Other Derivative Acquisition | +195 | -- |
| 2026-05-06 | John Danhakl | Independent Director | Other Derivative Acquisition | +185 | -- |
| 2026-05-06 | Leslie Morris | Independent Director | Other Derivative Acquisition | +171 | -- |
| 2026-05-06 | Colleen Goggins | Independent Director | Other Derivative Acquisition | +214 | -- |
| 2026-05-06 | James Fasano | Independent Director | Other Derivative Acquisition | +228 | -- |
| 2026-04-22 | John Danhakl | Independent Director | Other Acquisition | +1,571 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
IQVIA Holdings discussion 0 comments